期刊
EYE
卷 23, 期 6, 页码 1254-1268出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/eye.2009.43
关键词
choroidal melanoma; I-125; brachytherapy; complications; review
资金
- Prevent Blindness Inc.
- Frederic G Rappaport Fellowship Award
Uveal melanoma has traditionally been treated with enucleation, plaque brachytherapy, or external beam radiation. Following the results of the multicenter Collaborative Ocular Melanoma Study (COMS), which established no significant difference in mortality rates between enucleation and brachytherapy, plaque brachytherapy has become the favoured modality given its potential for preservation of vision and the eye. Among the radioisotopes that have been used, iodine-125 (I-125) has become the increasingly popular choice in the United States. However, I-125 brachytherapy is associated with complications, including keratitis, iris neovascularization, neovascular glaucoma, radiation retinopathy, and optic neuropathy. The purpose of this review is to discuss the pathogenesis, clinical presentation, and management of complications related to I-125 plaque brachytherapy for choroidal melanoma. Eye (2009) 23, 1254-1268; doi:10.1038/eye.2009.43; published online 6 March 2009
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据